Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Catalent Pharma Solutions, LLC
EIR
•Catalent Pharma Solutions, LLC•July 13, 2018

Catalent Pharma Solutions, LLC – FDA EIR, Jul 13, 2018

Record Details

An FDA inspection of Catalent, Inc. at its Somerset, NJ facility occurred from July 11-13, 2018. The inspection focused on compliance with Post-marketing Adverse Drug Experience (PADE) Reporting Regulations. Although the inspection concluded with "No Action Indicated" and no FDA Form 483 was issued, several issues were discussed with management. Key observations included the late submission of an expedited Individual Case Safety Report (ICSR CAT-000162-2016) to the FDA, which was 42 days overdue. Furthermore, one safety exchange agreement with a customer was deemed inadequate as it lacked specific timeframes for exchanging adverse drug experience information. The inspection also noted the absence of a dedicated Standard Operating Procedure for handling adverse drug experiences received by the legal department, despite employees receiving training. Some employees were identified as needing refresher training for adverse event procedures, and internal record retention policies required review to ensure full FDA compliance. Catalent management committed to addressing these observations, pledging to promptly amend the inadequate safety exchange agreement, ensure timely submission of future ICSRs, and review record retention procedures for compliance. This inspection highlighted areas for improvement in pharmacovigilance processes, despite no significant regulatory action being required.

Company
Catalent Pharma Solutions, LLC
Inspection date
July 13, 2018
Product type
drugs
Office
New Jersey District Office
People
  • Denise Ventre (company_representative)
  • Enrica Picard (company_representative)
  • John Chiminski (company_representative)
  • Larisa M. Corsate (company_representative)
  • Scott Gunther (company_representative)
View Company Profile

ID · 75ff88e2-c503-4f31-80d2-a26de1dcbdd3

Violation Codes2
21 CFR 820.19821 CFR 211

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Catalent Pharma Solutions, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.